Sartorius Stedim Biotech SA
PAR:DIM
Wall Street
Price Targets
DIM Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for
DIM
is 252.72 EUR
with a low forecast of 202 EUR and a high forecast of 325.5 EUR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Sartorius Stedim Biotech SA
For the last 8 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's operating income is
6%.
The projected
CAGR
for the next 3 years is
29%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DIM's stock price target?
Price Target
252.72
EUR
According to Wall Street analysts, the average 1-year price target for
DIM
is 252.72 EUR
with a low forecast of 202 EUR and a high forecast of 325.5 EUR.
What is Sartorius Stedim Biotech SA's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's revenue is
13%.
The projected
CAGR
for the next 3 years is
11%.
What is Sartorius Stedim Biotech SA's Operating Income forecast?
Projected CAGR
29%
For the last 8 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's operating income is
6%.
The projected
CAGR
for the next 3 years is
29%.
What is Sartorius Stedim Biotech SA's Net Income forecast?
Projected CAGR
56%
For the last 8 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's net income is
2%.
The projected
CAGR
for the next 3 years is
56%.
You don't have any saved screeners yet
